Faurobert E, Chen C K, Hurley J B, Teng D H
Howard Hughes Medical Institute and the Department of Biochemistry, University of Washington, Box 357370, Seattle, Washington 98195, USA.
J Biol Chem. 1996 Apr 26;271(17):10256-62. doi: 10.1074/jbc.271.17.10256.
Neurocalcins belong to a family of neuronal specific EF hand Ca2+-binding proteins defined by recoverin. Previously, we reported the cloning and initial characterization of neurocalcin in Drosophila melanogaster (Teng, D. H.-F., Chen, C.-K., and Hurley, J. B. (1994) J. Biol. Chem. 269, 31900-31907). We showed that the Drosophila neurocalcin protein (DrosNCa) is expressed in neurons and that bacterially expressed recombinant DrosNCa (rDrosNCa) can be myristoylated. Here, we present two lines of evidence that DrosNCa is fatty acylated in vivo. First, the mobility of affinity-purified native DrosNCa on two-dimensional gel electrophoresis is identical to that of myristoylated rDrosNCa and distinct from that of nonacylated rDrosNCa. Second, the membrane binding properties of native DrosNCa are similar to those of myristoylated rDrosNCa; both of these proteins bind to membranes at 0.2 mM Ca2+, whereas nonacylated rDrosNCa always remains soluble. It has been shown that recoverin inhibits the phosphorylation of rhodopsin when Ca2+ is present (Kawamura et al., 1993) and that a dependent recoverin/rhodopsin kinase interaction underlies the inhibitory effect of recoverin (Chen et al., 1995). Given the similarities between recoverin and neurocalcin, we examined the effect of DrosNCa on rhodopsin phosphorylation. We find that rDrosNCa is capable of inhibiting bovine rhodopsin phosphorylation in vitro in a Ca2+-dependent manner. The inhibitory activity of rDrosNCa is enhanced by myristoylation, and the potency of its effect is similar to that of recoverin. Two other related EF hand proteins, guanylate cyclase-activating protein-2 and calmodulin, are only poor inhibitors in these phosphorylation assays. in vitro inhibition of rhodopsin phosphorylation therefore appears to be an assayable property of a subset of recoverin-like proteins.
神经钙蛋白属于由恢复蛋白定义的神经元特异性EF手型Ca2+结合蛋白家族。此前,我们报道了黑腹果蝇中神经钙蛋白的克隆及初步特性研究(邓,D. H.-F.,陈,C.-K.,和赫尔利,J. B.(1994年)《生物化学杂志》269,31900 - 31907)。我们表明果蝇神经钙蛋白(DrosNCa)在神经元中表达,并且细菌表达的重组DrosNCa(rDrosNCa)可以被肉豆蔻酰化。在此,我们提供两条证据表明DrosNCa在体内被脂肪酰化。首先,亲和纯化的天然DrosNCa在二维凝胶电泳上的迁移率与肉豆蔻酰化的rDrosNCa相同,与未酰化的rDrosNCa不同。其次,天然DrosNCa的膜结合特性与肉豆蔻酰化的rDrosNCa相似;这两种蛋白质在0.2 mM Ca2+时都与膜结合,而未酰化的rDrosNCa始终保持可溶。已经表明,当存在Ca2+时恢复蛋白会抑制视紫红质的磷酸化(川村等人,1993年),并且恢复蛋白依赖性的恢复蛋白/视紫红质激酶相互作用是恢复蛋白抑制作用的基础(陈等人,1995年)。鉴于恢复蛋白和神经钙蛋白之间的相似性,我们研究了DrosNCa对视紫红质磷酸化的影响。我们发现rDrosNCa能够在体外以Ca2+依赖性方式抑制牛视紫红质的磷酸化。rDrosNCa的抑制活性通过肉豆蔻酰化增强,其作用效力与恢复蛋白相似。另外两种相关的EF手型蛋白,鸟苷酸环化酶激活蛋白 - 2和钙调蛋白,在这些磷酸化测定中只是较弱的抑制剂。因此,视紫红质磷酸化的体外抑制似乎是恢复蛋白样蛋白亚群的一种可检测特性。